Cargando…
Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal
PURPOSE: The purpose of the study was to compare efficacy and toxicity of olanzapine (OLN; a higher-cost drug) and haloperidol (HAL; a lower-cost drug) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients who receive highly emetogenic chemotherapy (HEC). PATIENTS AND METH...
Autores principales: | Dulal, Soniya, Paudel, Bishnu Dutta, Neupane, Prakash, Shah, Aarati, Acharya, Bibek, Poudyal, Bishesh Sharma, Shilpakar, Ramila, Wood, Lori Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528728/ https://www.ncbi.nlm.nih.gov/pubmed/31013182 http://dx.doi.org/10.1200/JGO.18.00245 |
Ejemplares similares
-
Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal
por: Shilpakar, Ramila, et al.
Publicado: (2019) -
Reliance on Self-Medication Increase Delays in Diagnosis and Management of GI Cancers: Results From Nepal
por: Dulal, Soniya, et al.
Publicado: (2020) -
Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th–25th September 2022, Kathmandu, Nepal
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2022) -
Overview of Delivery of Cancer Care in Nepal: Current Status and Future Priorities
por: Gyawali, Bishal, et al.
Publicado: (2020) -
Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting
por: Gyawali, Bishal, et al.
Publicado: (2016)